Journal of Market Access & Health Policy
Volume 6, 2018 - Issue 1
Open access
1,871
Views
3
CrossRef citations to date
0
Altmetric
Original Research Article
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
Emilie ClayHealth Economic Outcome Research, Creativ-Ceutical, Paris, FranceCorrespondence[email protected]
View further author information
, View further author information
Aurélien JamotteHealth Economic Outcome Research, Creativ-Ceutical, Paris, France
http://orcid.org/0000-0003-2274-4361View further author information
Peter VerhammeDepartment of Cardiovascular Sciences, University of Leuven, Leuven, BelgiumView further author information
, Alexander T. CohenDepartment of Thrombosis and Haemostasis, Guy’s & St. Thomas’ Hospital, London, UKView further author information
, Ben. A. Van HoutSchool for Health and Related Research, University of Sheffield, Sheffield, UKView further author information
& Pearl. GumbsMarket Access, Daiichi Sankyo Europe, Munich, GermanyView further author information
Article: 1495974
|
Received 27 Mar 2018, Accepted 27 Jun 2018, Published online: 17 Jul 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.